Exane Derivatives’s Huntington Bancshares HBAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$301 Hold
25
﹤0.01% 640
2022
Q1
$366 Hold
25
﹤0.01% 903
2021
Q4
$386 Sell
25
-3,743
-99% -$59K ﹤0.01% 799
2021
Q3
$58.3K Sell
3,768
-4,845
-56% -$71.3K 0.01% 603
2021
Q2
$122K Buy
+8,613
New +$132K 0.03% 516

Other funds holding HBAN

Exane Derivatives's HBAN Position: Q2 2022 in Review

Exane Derivatives held its Huntington Bancshares (HBAN) position steady in Q2 2022 at 25 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Exane Derivatives first reported a position in HBAN in Q2 2021 and has held it in 5 quarters since. The position peaked at $122K in Q2 2021. 873 funds tracked by Wall St. Rank hold HBAN as of Q2 2022.

  • Exane Derivatives held 25 shares of Huntington Bancshares worth $301 as of Q2 2022.
  • Exane Derivatives left its Huntington Bancshares share count unchanged in Q2 2022.
  • Huntington Bancshares made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #640 holding.
  • Exane Derivatives first reported a position in Huntington Bancshares in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's Huntington Bancshares position peaked at $122K in Q2 2021.
  • 873 funds tracked by Wall St. Rank held Huntington Bancshares as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.